# Oral Propranolol for Prevention of Threshold Retinopathy of Prematurity

> **NCT03083431** · PHASE2 · RECRUITING · sponsor: **University of Zurich** · enrollment: 276 (estimated)

## Conditions studied

- Retinopathy of Prematurity

## Interventions

- **DRUG:** Propranolol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03083431
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-22
- **Primary completion:** 2028-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 276 (ESTIMATED)
- **Last updated:** 2026-05-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03083431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03083431, "Oral Propranolol for Prevention of Threshold Retinopathy of Prematurity". Retrieved via AI Analytics 2026-09-01 from https://api.ai-analytics.org/clinical/NCT03083431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*